/Investor DB

Tabula Rasa Ventures

Venture capital

Pre-Seed–Series A · 14 people tracked

Find your way into Tabula Rasa Ventures

Sign up to see every warm intro you have to Tabula Rasa Ventures

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Tabula Rasa Ventures team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Tabula Rasa Ventures backs early-stage startups advancing human health and transforming health systems, spanning technology, digital therapeutics, healthcare infrastructure, and drug development. The firm deploys checks of $50k to $1M into pre-seed through Series A companies. While structured as a VC firm, it operates like an accelerator in its founder relationships, acting as an extension of the team and helping startups overcome their biggest obstacles. The firm also values non-paid partnerships that bring meaningful benefit to its portfolio companies.

Source: firm website, verified Oct 2, 2026.

Stage
Pre-Seed–Series A
Check
$50K – $1M
Instruments
Equity
Tracked investments
21

Team · 14 people

from the firm's website & public directories
Maria Velkova· Managing Partner
John Turner· Advisor
Judy Blumstock· Advisor
Liz Stahura· Advisor
Magenta Ceiba· Advisor
Maya Albert· Head of Operations
Olav Sorenson· Advisor
Prav Pillay· Advisor
Rob Laurie· Advisor
Tanya Harding· Advisor

What they invest in

from 13 of 21 portfolio companies

Healthtech ×9Digital Health ×6Biotech ×5Mental Health ×5AI & Machine Learning ×3Deep Tech ×3Enterprise Software ×3InsurTech ×2

HQs:United States×8

Investments · 21 tracked

founders shown can be your intro path

By year:2022 · 12021 · 12 dated

2A Biosciences2abiosci.comin𝕏

2AB BioscienceS develops first-in-class small molecule therapeutics targeting the 5-HT2A receptor for ophthalmology and central nervous system disorders.

BiotechDeep TechDigital HealthEdTechHealthtechMedical DevicesSanta Monica, US

Alex Speiser(Co-Founder & Chief Executive Officer)inCharles Nichols, PhD(Co-Founder & Chief Science Officer)David Nichols, PhD(Co-Founder & Head of Chemistry)Tim Foster, PhD(Co-Founder & Head of Translational Discovery)

BoardGopal Das(Director)

Co-investorsGaingelsLIONHEART VENTURESPalo Santo VCWhat If Ventures

Ameraamerahealthsolutions.cominSeed

Amera Health Solutions provides a data integration platform that connects fragmented claims processing systems for health plans.

Data & InfrastructureEnterprise SoftwareFintechHealthtechInsurTechNew York City, US

Deep Kapur(CEO)inLouise Tanski(Founder)in

Co-investorsValia VenturesY CombinatorAlumni VenturesBase10 PartnersC Square CapitalComma Capital+7 more

Big Leap Healthbigleaphealth.com

Big Leap Health operates an online directory that connects patients with in-network mental health clinics offering insurance-covered treatments such as TMS (Transcranial Magnetic Stimulation) and Spravato (esketamine).

Digital HealthMarketplacesMental Health

Co-investorsEverywhere Ventures

CellTypecelltype.cominSeed

CellType uses AI agents and biological models to automate drug discovery, having identified a novel cancer treatment signal and partnering with major pharmaceutical companies.

BiotechHealthtechNew York City, US

David van Dijk(Co-founder & CEO)inIvan Vrkic(Co-founder)in

Co-investorsACVC PartnersEight CapitalPioneerY CombinatorZAKA VC0 AD+13 more

DeepWell DTxdeepwelldtx.com

DeepWell DTx develops over-the-counter video games that combine interactive media with digital therapeutics to treat mental health conditions at scale, using real-time biofeedback to guide breathing exercises.

Digital HealthGamingMental Health

Ryan Douglas(Co-founder & Co-chair)

Entheaenthea.cominDec 2022

Enthea provides access to mental health treatment, including psychedelic-assisted therapy, positioned as a safe and affordable benefit for employers and healthcare consumers.

Digital HealthHealthtechHR TechInsurTechMental HealthBoston, US

Sherry Rais(CEO)in

Co-investorsChicago Early Growth Ventures (CEGV)JLS

Lykos Therapeutics fka MAPS PBClykospbc.comin𝕏

Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.

BiotechDeep TechMental Health

Co-investorsJourneyOne VenturesLauder PartnersLeafy TunnelSolari CapitalWGD Capital, L.P.XEIA Venture Partners

Olden Labsoldenlabs.com

Olden Labs builds DOME Smart Lids, an automated home-cage monitoring system that tracks digital biomarkers, health, and behavior of lab animals without disrupting their environment.

BiotechHardwareHealthtech

Michael Florea(Founder)in

Co-investorsCarbon SiliconCentre Street PartnersStartX

Opalite Healthopalitehealth.cominSeed

Opalite builds language interpretation technology for healthcare, enabling real-time communication between physicians and patients across language barriers.

AI & Machine LearningDigital HealthHealthtechSan Francisco, US

Cathleen Kuo(CEO)inAlex Mehregan(CTO)in

Co-investorsRebel FundSterling RoadY Combinator007 Venture PartnersBlast.ClubCoyote Ventures+6 more

Rhizome AIrhizomeai.cominSeed

Rhizome AI provides an AI research platform that answers regulatory and clinical questions by citing documents from health authority databases across multiple markets, with built-in hallucination prevention.

AI & Machine LearningEnterprise SoftwareHealthtechNew York City, US

Chetan Mishra(CEO)in

Co-investorsY Combinator

Ruma Carerumacare.cominSeed

Ruma provides prior authorization software for healthcare practices, helping clinics manage and scale authorization requests across multiple locations.

Enterprise SoftwareHealthtechSaaSSan Francisco, US

Meng Fei Shen(CEO)inChristina Huang(Founder)in

Co-investorsRebel FundY CombinatorBlast.ClubRobinhoodxfactor ventures

Strand AIstrandai.comin𝕏Seed

Strand AI predicts missing biological data modalities from existing patient data, converting single histopathology slides into spatial protein maps and inferring gene expression from genotype.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Yue Dai(CEO)inOded Falik(CTO)in

Co-investorsAkkaMarble Creek VenturesY CombinatorAndreessen HorowitzBain Capital Ventures

Wavepathswavepaths.comin𝕏Nov 2021

Wavepaths develops adaptive therapeutic music designed to support mental health and wellness practitioners in their sessions.

Digital HealthMental HealthWellness & Fitness

Mendel Kaelen(Founder & CEO)in

Co-investorsMITONReflex CapitalEmpath VenturesLIONHEART VENTURESNeo Kuma VenturesPalo Santo VC

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

2AApolloNatural MedtechPsynauticsTerranTerran BiosciencesThe Synthesis Institute

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Tabula Rasa Ventures made?
Tabula Rasa Ventures has 21 tracked investments.
What stage does Tabula Rasa Ventures invest at?
Tabula Rasa Ventures invests at the Pre-Seed, Seed, Series A stages.
What is Tabula Rasa Ventures's typical check size?
Tabula Rasa Ventures typically writes checks of $50K – $1M.
What sectors does Tabula Rasa Ventures focus on?
Tabula Rasa Ventures focuses on Biotech, Digital Health, Enterprise Software, Fintech, Healthtech.
Who does Tabula Rasa Ventures co-invest with?
Tabula Rasa Ventures most often shares deals with Carbon Silicon, Gaingels, Lauder Partners, among 16 tracked co-investors.

Media · Podcasts & interviews

featuring the team

King Connections Podcast - Maria Velkova

King Christopher · Maria Velkova

Similar investors

Featured in lists